GE HealthCare (Nasdaq: GEHC) has agreed to acquire Intelerad, a provider of medical imaging software for the health care industry, for $2.3 billion in cash.
And supporting ambulatory care appears to be a main catalyst for the deal, the companies suggested in a press release announcing the news.
This acquisition also reflects GE HealthCare’s commitment to cloud-based, AI-driven solutions across different care environments and supports the company’s goal to triple its cloud-enabled product lineup by 2028.
Intelerad has a strong presence in outpatient ambulatory care settings. Its cloud-first products are designed for radiology and cardiology and span both inpatient and outpatient care environments.
“As hospital and ambulatory care providers face increased demand for imaging and rising patient volumes, they are looking to simplify and unify their workflows,” Peter Arduini, president and CEO of GE HealthCare, said in a press release. “Our acquisition of Intelerad will bring additional cloud-enabled and intelligent solutions in radiology and cardiology into our portfolio of products and extend our capabilities into outpatient networks, enabling care teams to be more efficient, improve outcomes and deliver precision care for patients globally. As a result, we expect to accelerate our growth in SaaS products and recurring revenues as we take another evolutionary step to grow into a health care solutions provider.”
The acquisition complements GE HealthCare’s inpatient footprint by expanding into outpatient and ambulatory care settings.
“Intelerad is an outstanding strategic fit and is a pioneer in cloud-based imaging software, with a strong portfolio of solutions across care settings,” Roland Rott, president and CEO of Imaging at GE HealthCare, said. “By combining GE HealthCare’s medical device and AI competence at a global scale with Intelerad’s enterprise cloud and imaging expertise, we will be better positioned to meet the evolving needs of health care providers, simplify complex workflows, and drive digital innovation across the country.”
The transaction is expected to be completed in the first half of 2026, subject to customary closing conditions and regulatory approvals.
GE HealthCare declined an opportunity to comment on this ASC News story.
